Boryung Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers various active pharmaceutical ingredients, including doxorubicin hydrochloride, tamsulosin hydrochloride, epirubicin hydrochloride, glimepiride, captopril, alibendole, alacepril, torsemide, nitrendipine, fluconazole, and ondansetron hydrochloride. It also manufactures and licenses various finished products in the areas of antibiotics, dermatology, cardiovascular, antineoplastics and antiemetics, urology, gastrointestinal, amino acids injections, dialysis, antidiabetes, CNS, vaccines, respiratory, anti-histamines, and ophthalmics, as well as antipyretic, analgesics, anti-inflammatory, and other areas. The company was formerly known as Boryung Drugs Co., Ltd. and changed its name to Boryung Pharmaceutical Co., Ltd. in February 1966. Boryung Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Seoul, South Korea.
boryung pharmaceutical co
Phone: 82 2 708 8000
Sponsored Financial Commentaries
To contact BORYUNG PHARMACEUTICAL CO, please visit www.boryung.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.